Skip to main content

Table 2 Preoperative data on the two patient group

From: Efficacy of interleukin-6 in combination with D-dimer in predicting early poor postoperative prognosis after acute stanford type a aortic dissection

Valuables Group A (n = 107) Group B (n = 34) P value
Male, n (%) 80 (74.8) 25 (73.5) 0.885
Age,n (year) 51.6 ± 10.6 50.6 ± 11.9 0.660
BMI (Kg/Mˆ2) 25.8 ± 3.9 25.6 ± 4.2 0.754
IL-6(pg/mL) 57.8 ± 39.0 211.0 ± 153.7 <0.001
D-dimer (ug/mL) 7.3 ± 6.1 16.7 ± 5.8 <0.001
Leukocyte(10ˆ9/L) 12.3 ± 4.0 12.8 ± 4.7 0.540
Neutrophile granulocyte(10ˆ9/L) 10.3 ± 3.9 10.8 ± 4.3 0.553
Leukomonocyte (10ˆ9/L) 1.1 ± 0.5 1.1 ± 0.6 0.924
PT (sec) 15.7 ± 13.7 15.7 ± 4.9 0.982
Heamoglobin(g/L) 129.5 ± 23.6 126.7 ± 23.3 0.553
Albumin(g/L) 37.3 ± 5.4 35.4 ± 4.6 0.056
Troponin-I (ug/L) 0.3 ± 1.0 1.9 ± 6.5 0.158
NT-ProBNP (pg/mL) 704.1 ± 1156.7 1993.0 ± 6129.2 0.231
Serum creatinine (umol/L) 93.1 ± 42.4 136.5 ± 127.7 0.060
Lactic acid (mmol/L) 2.0 ± 1.3 1.6 ± 1.3 0.178
Alanine aminotransferase (IU/L) 63.0 ± 169.8 166.5 ± 473.0 0.219
Aspartate aminotransferase (IU/L) 69.0 ± 226.2 190.4 ± 456.3 0.145
EF (%) 63.8 ± 7.0 62.7 ± 6.2 0.371
Marfan Syndrome, n (%) 5 (4.7) 2 (5.9%) 0.865
Hypertension, n (%) 79 (73.8) 30 (88.2) 0.080
Diabetes, n (%) 9 (8.4) 1 (2.9) 0.485
Pericardial effusion (Medium or above), n (%) 5 (4.7) 4 (11.8) 0.715
MPS, n (%) 7 (6.5) 4 (11.8) 0.534
AR (Medium or above), n (%) 28 (26.2) 7 (20.6) 0.512
History of cardiac surgery, n (%) 8 (7.5) 4 (11.8) 0.669
  1. Continuous normally distributed variables were expressed as mean(±standard deviation) and not-normally distributed variables as medians (interquartile range)